Welcome to the ValueWiki CardioVascular BioTherapeutics, Inc. (CVBT) article! Register for free or click the "edit" link to contribute!    

CardioVascular BioTherapeutics, Inc. (CVBT)

From ValueWiki

Jump to: navigation, search
This summary section needs content! Click Here to begin writing.
Have a question about CardioVascular BioTherapeutics, Inc.? Ask it on the Message Board or Chat Room
Visit the Apple, Inc. page for an example of a complete article.

Contents

Today 5d 3m 6m 1y 2y 5y Max




Company Analysis

CardioVascular BioTherapeutics, Inc. Snapshot[1]
  • Outstading Shares: 124,653,737 as of 2006-10-31
  • Transfer Agent: American Stock Transfer & Trust Company, New York, NY 10038
CardioVascular BioTherapeutics, Inc. Contact Information
  • Address: 1635 Village Center Circle Suite 250 Las Vegas, NV 89134 USA
  • Website: http://www.cvge.com/
  • Phone: 702-839-7200

News Feed

11/25/08 8:11 am CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease (PR Newswire)
11/14/08 6:11 am CARDIOVASCULAR BIOTHERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statem (EDGAR Online)
11/13/08 8:11 am CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate (PR Newswire)
11/12/08 6:11 am CARDIOVASCULAR BIOTHERAPEUTICS, INC. Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial S (EDGAR Online)
11/04/08 6:11 am CARDIOVASCULAR BIOTHERAPEUTICS, INC. Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial S (EDGAR Online)
11/03/08 4:11 pm CARDIOVASCULAR BIOTHERAPEUTICS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant (EDGAR Online)
09/11/08 9:09 am CARDIOVASCULAR BIOTHERAPEUTICS, INC. Financials (EDGAR Online Financials)
09/09/08 7:09 am CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial (PR Newswire)
09/02/08 5:09 am CARDIOVASCULAR BIOTHERAPEUTICS, INC. Files SEC form 8-K, Other Events (EDGAR Online)
08/19/08 4:08 pm CARDIOVASCULAR BIOTHERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report (EDGAR Online)
More News...

Leadership

Daniel C. Montano, CEO

Risks

This section needs content! Click the blue edit link (to the right) to contribute.

Research Links

CardioVascular BioTherapeutics, Inc. Fundamentals
CardioVascular BioTherapeutics, Inc. Technical Analysis
CardioVascular BioTherapeutics, Inc. Message Boards

Notes

  1. http://www.pinksheets.com/quote/company_profile.jsp?symbol=CVBT
Personal tools